Monopar Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-14 16:50:29 ET MNPR

Published on 05/14/2026 at 04:50 pm EDT

Monopar Therapeutics Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported net loss was USD 3.89 million compared to USD 2.62 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 0.38 a year ago.

Diluted loss per share from continuing operations was USD 0.46 compared to USD 0.38 a year ago.